The clinical significance of pituitary-adrenal suppression by exogenous corticosteroids.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000307:Adrenal Gland Diseases / Q000139:chemically induced; D000324:Adrenocorticotropic Hormone; D006801:Humans; D008797:Metyrapone; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone